1. Unit startpage
  2. Employees
  3. Anders Vik
No picture, placeholder image
No picture, placeholder image
Førsteamanuensis Translational Vascular Research Group anders.vik@uit.no

Anders Vik

  • Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias Schmidt Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold :
    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
    Blood Cancer Journal 2024 ARKIV / DOI
  • Alicia Villatoro, Vincent Cuminetti, Aurora Bernal Mera, Carlos Torroja, Itziar Cossío, Alberto Benguría et al.:
    Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
    Nature Communications 2023 ARKIV / DOI
  • Milton Boaheng Antewi, Gianina Aurica Dumitriu, Jaione Santamaria Simon, Javier Sanchez Romano, Ruomei Li, Bård Smedsrød et al.:
    Liver sinusoidal endothelial cells show reduced scavenger function and downregulation of Fc gamma receptor IIb, yet maintain a preserved fenestration in the Glmp gt/gt mouse model of slowly progressing liver fibrosis
    PLOS ONE 2023 ARKIV / DOI
  • Fridtjof Balteskard Rinde, Synne Grønvold Frønæs, Waleed Khalid Ghanima, Anders Vik, John-Bjarne Hansen, Sigrid Brækkan :
    D-dimer as a stand-alone test to rule out deep vein thrombosis
    Thrombosis Research 2020 ARKIV / DOI
  • Ludvig Balteskard Rinde, Birgit Småbrekke, Erin Mathisen Hald, Ellen Elisabeth Brodin, Inger Njølstad, Ellisiv B. Mathiesen et al.:
    Myocardial infarction and future risk of cancer in the general population?the Troms? Study
    European Journal of Epidemiology (EJE) 2017 ARKIV / DOI
  • Anders Vik, Ellen Elisabeth Brodin, Ellisiv B. Mathiesen, Jan Brox, Lone Jørgensen, Inger Njølstad et al.:
    Serum osteoprotegerin and renal function in the general population: The Troms? Study
    Clinical Kidney Journal (CKJ) 2017 ARKIV / DOI
  • Birgit Småbrekke, Ludvig Balteskard Rinde, Kristian Hindberg, Erin Mathiesen Hald, Anders Vik, Tom Wilsgaard et al.:
    Atherosclerotic risk factors and risk of myocardial infarction and venous thromboembolism; Time-fixed versus time-varying analyses. The Troms? Study
    PLOS ONE 2016 ARKIV / DOI
  • Ynse Ieuwe Gerardus Vladimir Tichelaar, Ellen Elisabeth Brodin, Anders Vik, Trond Isaksen, Finn Egil Skjeldestad, Satish Kumar et al.:
    A retrospective comparison of ultrasound-assisted catheter-directed thrombolysis and catheter-directed thrombolysis alone for treatment of proximal deep vein thrombosis
    Cardiovascular and Interventional Radiology 2016 ARKIV / DOI
  • Ludvig Balteskard Rinde, Caroline Lind, Birgit Småbrekke, Inger Njølstad, Ellisiv B. Mathiesen, Tom Wilsgaard et al.:
    Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study
    Journal of Thrombosis and Haemostasis 2016 ARKIV / DOI
  • Trond Isaksen, Ynse Ieuwe Gerardus Vladimir Tichelaar, Finn Egil Skjeldestad, Ellen Elisabeth Brodin, Anders Vik, Kulbir Singh et al.:
    Inter-rater agreement between professional-rated and patient-rated scores of the Villalta scale for evaluation of the post-thrombotic syndrome
    Thrombosis Research 2016 DOI
  • Jostein Lappegård, Trygve Ellingsen, Anders Vik, Tove Skjelbakken, Jan Brox, Ellisiv B. Mathiesen et al.:
    Red cell distribution width and carotid atherosclerosis progression: The tromsø study
    Thrombosis and Haemostasis 2015 ARKIV / DOI
  • Anders Vik, Ellen Elisabeth Brodin, Ellisiv B. Mathiesen, Jan Brox, Lone Jørgensen, Inger Njølstad et al.:
    Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study
    European Journal of Epidemiology (EJE) 2014 ARKIV / DOI
  • Emilio Besada, Anders Vik, Wenche Koldingsnes, Johannes C Nossent :
    Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review
    International journal of hematology 2013 DOI
  • Erin Mathiesen Hald, Sigrid Kufaas Brækkan, Anders Vik, Ellen Elisabeth Brodin, John-Bjarne Hansen :
    Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism
    Journal of Clinical Lipidology 2013 DOI
  • Ellen Elisabeth Brodin, Gunhild Lerstad, Guri Grimnes, Sigrid Kufaas Brækkan, Anders Vik, Jan Brox et al.:
    Serum levels of vitamin D are not associated with future risk of venous thromboembolism The Tromso Study
    Thrombosis and Haemostasis 2013 DOI
  • Lone Jørgensen, John-Bjarne Hansen, Luai A. Ahmed, Åshild Bjørnerem, Nina Emaus, Ragnar Martin Joakimsen et al.:
    Osteoprotegerin is associated with hip fracture incidence: the Tromso Study
    International Journal of Epidemiology 2012 SAMMENDRAG / DOI
  • Ellen Elisabeth Brodin, Sigrid Kufaas Brækkan, Anders Vik, Jan Brox, John-Bjarne Hansen :
    Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study
    Haematologica 2012 ARKIV / DOI
  • Lone Jørgensen, John-Bjarne Hansen, Jan Brox, Ellisiv B. Mathiesen, Anders Vik, Bjarne K. Jacobsen :
    Serum osteoprotegerin levels are related to height loss: The Tromsø Study
    European Journal of Epidemiology (EJE) 2011 FULLTEKST / ARKIV / DOI
  • Anders Vik, Ellisiv B. Mathiesen, Jan Brox, Tom Wilsgaard, Inger Njølstad, Lone Jørgensen et al.:
    Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromso Study
    Journal of Thrombosis and Haemostasis 2011 DOI
  • Marie Søfteland Sandvei, Ellisiv B. Mathiesen, Lars Johan Vatten, Tomm Brostrup Müller, Haakon Lindekleiv, Tor Ingebrigtsen et al.:
    Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984-2007
    Neurology 2011 DOI
  • Sigbjørn Berentsen, Ulla Randen, Anna Marita Vågan, Henrik Hjort-Hansen, Anders Vik, Jakob Dalgaard et al.:
    High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
    Blood 2010 FULLTEKST / DOI
  • Anders Vik, Ellisiv B. Mathiesen, jan Brox, Tom Wilsgaard, Inger Njølstad, Lone Jørgensen et al.:
    Relation between serum osteoprotegerin and carotid intima media thickness in a general population - The Tromsø Study
    Journal of Thrombosis and Haemostasis 2010 DOI
  • Lone Jørgensen, Anders Vik, Nina Emaus, Jan Brox, John-Bjarne Hansen, Ellisiv B. Mathiesen et al.:
    Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappa B ligand: the Tromso Study
    Osteoporosis International 2010 DOI
  • Anders Vik, Ellisiv B. Mathiesen, Stein Harald Johnsen, Jan Brox, Tom Wilsgaard, Inger Njølstad et al.:
    Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population - the Troms circle divide study
    Journal of Thrombosis and Haemostasis 2010 DOI
  • Anders Vik, Guanglin Cui, vidar Isaksen, T Wik, John-Bjarne Hansen :
    Erythropoietin Production by a Hepatic Adenoma in a Patient with Severe Erythrocytosis
    Acta Haematologica 2009 DOI
  • Lone Jørgensen, Anders Vik, Nina Emaus, jan Brox, John-Bjarne Hansen, Ellisiv B. Mathiesen et al.:
    Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappa B ligand: the Tromsø Study
    Osteoporosis International 2009
  • Anders Vik, Ellisiv B. Mathiesen, Ann-Trude With Notø, Baldur Sveinbjørnsson, jan Brox, John-Bjarne Hansen :
    Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
    Atherosclerosis 2007 DOI
  • Anders Vik, Ellen Elisabeth Brodin, Baldur Sveinbjørnsson, John-Bjarne Hansen :
    Heparin induces mobilization of osteoprotegerin into the circulation
    Thrombosis and Haemostasis 2007 DOI
  • Anders Vik, Ellen Elisabeth Brodin, Trond Børvik, Baldur Sveinbjørnsson, John-Bjarne Hansen :
    Serum osteoprotegerin in young survivors of myocardial infarction
    Thrombosis and Haemostasis 2006
  • Anders Vik, Ellisiv B. Mathiesen, Ann-Trude With Notø, Baldur Sveinbjørnsson, Jan Brox, John-Bjarne Hansen :
    Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
    Atherosclerosis 18. April 2006
  • Anders Vik, reidar Berntsen, vidar Isaksen, Egil Haug, John-Bjarne Hansen :
    Ein 53 år gammal mann med hovudverk og konsentrasjonsvanskar
    Tidsskrift for Den norske legeforening 2005
  • Anders Vik, Satish Kumar, Kulbir Singh, John-Bjarne Hansen :
    Lokal trombolytisk behandling og stent ved stenose i v. cava superior
    Tidsskrift for Den norske legeforening 2003
  • Anders Vik, Nina Helbekkmo, Roy M. Bremnes :
    Låggradig non-Hodgkins lymfom i Nord-Noreg
    Tidsskrift for Den norske legeforening 2002
  • Roy M. Bremnes, Anders Vik, Nina Helbekkmo :
    Low-grade non-Hodgkin's lymphoma in northern Norway: treatment, outcome, and prognostic factors
    Anticancer Research 1998
  • Vincent Cuminetti, Joanna Konieczny, Aurora Bernal Mera, Marc Ferre Oliver, Manuel José Gomez, Nuria Vilaplana-Lopera et al.:
    Succinate receptor 1 signaling regulates hematopoiesis via S100/a8 and S100/a9 in health and malignancy
    2024
  • Alicia Elena Villatoro Gonzalez, Vincent Cuminetti, Aurora Bernal Mera, Carlos Torroja, Itziar Cossío, Alberto Benguría et al.:
    Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)
    Nature Communications 2023 DOI
  • Vincent Cuminetti, Joanna Konieczny, Aurora Bernal, Alicia Villatoro, Hagar Taman, Marko Ristic et al.:
    Disruption of succinate receptor signaling promotes myeloproliferation and acute myeloid leukaemia
    HemaSphere 2022 DOI
  • Hilde Jensvoll, Marie Falkenberg Smeland, Heidi Tiller, Øystein Lunde Holla, Trine Prescott, Anders Vik :
    En gravid kvinne med pancytopeni
    Tidsskrift for Den norske legeforening 2019 DOI
  • Anders Vik :
    Risiko for tilbakefall ved tidsbegrenset behandling av blodpropp
    2015 FULLTEKST
  • Anders Vik :
    Ny kunnskap om molekylære mekanismer kan gi nye angrepspunkt for forebygging av blodpropp
    2014 FULLTEKST
  • John-Bjarne Hansen, Ellen Elisabeth Brodin, Anders Vik, Sigrid Kufaas Brækkan :
    Tromboseprofylakse ved sykehusinnleggelse for akutte indremedisinske tilstander – fra retningslinjer til klinisk praksis
    2014 FULLTEKST
  • Anders Vik, vidar Isaksen, Jan Brox, John-Bjarne Hansen :
    Ei kvinne i 50-åra med hovudverk, uklart syn og utslett
    Tidsskrift for Den norske legeforening 2012 DOI
  • Anders Vik, Ellen Elisabeth Brodin, Sigrid Kufaas Brækkan, John-Bjarne Hansen :
    Serum osteoprotegerin and future risk of venous thromboembolism. The Tromso study
    Thrombosis Research 2012 DOI

    • The 50 latest publications is shown on this page. See all publications in Cristin here →

    Research interests

    Osteoprotegerin and cardiovascular disease

    Osteoprotegerin and cancer

    CV

    Academic degrees

    1989    Cand.med.vet (DVM), Norwegian school of veterinary science, Oslo

    1998    Cand.med (MD), University of Tromsø, Tromsø

    2010    PhD in medicine (Thesis title: "Osteoprotegerin and Cardiovascular Disease)